Apolipoprotein E polymorphism and low density lipoprotein (LDL) oxidation in patients with dementia.
In patients with dementia, 29 diagnosed as probably suffering from Alzheimer's disease and 46 subjects with dementia of vascular origin, and in 41 non demented control subjects LDL oxidation in vitro was compared in carriers of various apolipoprotein E alleles. Restriction isotyping was performed by gene amplification and cleavage with Hhal, LDL oxidation was investigated by determination of conjugated dienes and vitamin E (alpha tocopherol) plasma level was measured by HPLC. In subjects with dementia oxidation of LDL was shown to be higher in carriers of epsilon4 allele as compared with non-carriers of this allele. It was especially observed in the propagation phase, which illustrates oxidation intensity after the exhaustion of the antioxidant reserve in LDL. Vitamin E level did not show differences between carriers of different alleles. It is concluded that the differences in oxidation susceptibility of LDL between demented subjects possessing particular apolipoprotein E forms can result partially from differing antioxidant properties of apolipoprotein E isoforms and, in a substantial degree, from the size and quality of LDL.
Wehr
Hanna
H
Department of Genetics, Institute of Psychiatry and Neurology, Warszawa, Poland. wehr@ipin.edu.pl
Bednarska-Makaruk
Małgorzata
M
Graban
Ałła
A
Kunicki
Paweł K
PK
Lojkowska
Wanda
W
Rodo
Maria
M
Ryglewicz
Danuta
D
D000368:Aged; D000369:Aged, 80 and over; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics*; D003704:Dementia / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006579:Heterozygote; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D011110:Polymorphism, Genetic / Q000235:genetics*; D018709:Statistics, Nonparametric
D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D008077:Lipoproteins, LDL